Rentokil senses victory
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.RENTOKIL is expected to lift its pounds 1.26bn hostile bid for business services group BET this week to clinch victory in its bitter, two-month- long takeover battle.
In the increasingly acrimonious tussle, the Takeover Panel is this weekend investigating allegations that Rentokil spread false rumours about pressure on BET from leading institutions, including M&G and Legal & General, to negotiate an agreed deal.
Rentokil chief executive Clive Thompson says no firm decision on lifting the bid has yet been made: "We have until Friday. We'll be considering the matter this week. It's much too early to comment," he said.
Analysts, however, are looking for a token sweetener of 5p-15p per BET share to seal victory.
Rentokil shares ended strongly at 368 1/2p last week, valuing its cash and shares offer at 206p per share, against BET's 207p closing price.
BET's advisers ING Barings complained to the Takeover Panel last Wednesday over misleading suggestions that the group was coming under pressure from its own shareholders.
Rentokil denies dirty tricks, but the Panel has passed on its concerns to Rentokil's merchant bankers, Lazard's.
"It is an attempt to create a false impression of what institutions believe," one BET adviser said. "The true value of BET is only just becoming apparent. Shareholders will demand a fair value from Rentokil."
In its final defence last week, BET revised forecast profits for the current year up to pounds 146m from pounds 142m and predicted a 20 per cent rise in next year's dividend.
Despite the spat, Rentokil's unbroken 14-year history of growth is expected to tell in the end.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments